Cambridge, United Kingdom

Claire Wombwell

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Eleusis Therapeutics US, Inc.. Active years: 2022-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Claire Wombwell: Innovator in Pharmaceutical Science

Introduction

Claire Wombwell is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of pharmaceutical science, particularly in the development of novel therapeutic compositions. With a total of 3 patents to her name, her work focuses on innovative solutions for various medical conditions.

Latest Patents

Wombwell's latest patents include compositions featuring pharmaceutically acceptable salts of psilocin. These compositions are designed to treat a range of diseases and conditions, such as neurological injuries, inflammatory conditions, chronic pain, and psychological disorders. The innovative approach of utilizing these salts opens new avenues for treatment in patients who are in need.

Career Highlights

Throughout her career, Claire Wombwell has demonstrated a commitment to advancing medical science. Her work at Eleusis Therapeutics US, Inc. has positioned her as a key player in the pharmaceutical industry. She continues to explore the therapeutic potential of psilocin and its derivatives.

Collaborations

Wombwell has collaborated with esteemed colleagues in her field, including David E. Nichols and Graham Johnson. These partnerships have fostered a collaborative environment that enhances the research and development of her innovative projects.

Conclusion

Claire Wombwell's contributions to pharmaceutical science exemplify her dedication to improving healthcare through innovation. Her patents and ongoing research hold promise for the treatment of various medical conditions, showcasing her impact on the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…